Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth.

Kawabata A, Baoum A, Ohta N, Jacquez S, Seo GM, Berkland C, Tamura M

Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth.

Cancer research

72

8

2057

2067